CMS: Baltimore hospital violated EMTALA by leaving patient at bus stop

The University of Maryland Medical Center (UMMC) in Baltimore has been cited for several violations on patient rights and hospital regulations after leaving a patient wearing only a hospital gown at a bus stop in January. 

CMS had promised to investigate how the patient, identified only as Rebecca, was treated after seeing media coverage of a viral video of her being left outside, looking confused, in 30 degree weather. According to the report, obtained by the Baltimore Sun, CMS said Rebecca was taken to the hospital with a head wound after falling off a motorbike. Nurses said she resisted being discharged and was removed from the hospital by security as shown in the video.

UMMC violated several regulations in this incident, according to CMS, including the Emergency Medical Treatment and Labor Act (EMTALA) requiring anyone coming to an emergency department to be stabilized and treated. CMS said the hospital “enacted barriers to patients receiving care” in the ED by locking doors to ED and leaving it to security guards to decide what patients should enter. CMS also said it failed to discharge the patient in a safe manner and also violated her right to receive care in a safe setting.

UMMC CEO Mohan Suntha, MD, said the hospital has been re-training and conducting spot audits on staff to make sure they’re following federal requirements. While doors to the ED won’t be locked, he said the hospital won’t be scaling back on security.

“We didn’t solve the problem by removing security,” Suntha said. “We solved the problem so that patients are still protected and staff are still protected in our solution.”

Read more at the link below:

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.